NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $0.59 -0.01 (-2.37%) As of 10:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Milestone Scientific Stock (NYSE:MLSS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Milestone Scientific alerts:Sign Up Key Stats Today's Range$0.58▼$0.6250-Day Range$0.43▼$0.9252-Week Range$0.38▼$1.39Volume52,020 shsAverage Volume218,826 shsMarket Capitalization$45.99 millionP/E RatioN/ADividend YieldN/APrice Target$1.25Consensus RatingBuy Company Overview Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey. Read More Milestone Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreMLSS MarketRank™: Milestone Scientific scored higher than 41% of companies evaluated by MarketBeat, and ranked 1338th out of 1,853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMilestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMilestone Scientific has received no research coverage in the past 90 days.Read more about Milestone Scientific's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Milestone Scientific is -8.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Milestone Scientific is -8.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMilestone Scientific has a P/B Ratio of 5.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.16% of the float of Milestone Scientific has been sold short.Short Interest Ratio / Days to CoverMilestone Scientific has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Milestone Scientific has recently increased by 12.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMilestone Scientific does not currently pay a dividend.Dividend GrowthMilestone Scientific does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.16% of the float of Milestone Scientific has been sold short.Short Interest Ratio / Days to CoverMilestone Scientific has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Milestone Scientific has recently increased by 12.03%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Milestone Scientific this week, compared to 1 article on an average week.Search Interest1 people have searched for MLSS on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Milestone Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $218,592.00 in company stock.Percentage Held by Insiders24.75% of the stock of Milestone Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.79% of the stock of Milestone Scientific is held by institutions.Read more about Milestone Scientific's insider trading history. Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address MLSS Stock News HeadlinesMilestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and MarketingAugust 6, 2025 | globenewswire.comMilestone Scientific Appoints Eric C. Hines as Chief Executive OfficerAugust 1, 2025 | globenewswire.comNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.August 12 at 2:00 AM | Brownstone Research (Ad)Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New JerseyJuly 17, 2025 | globenewswire.comMLSS Milestone Scientific Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comMilestone Scientific Inc. (MLSS) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comMilestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of DirectorsMay 19, 2025 | globenewswire.comMilestone Scientific, Inc.: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025May 17, 2025 | finanznachrichten.deSee More Headlines MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed this year? Milestone Scientific's stock was trading at $0.96 at the beginning of the year. Since then, MLSS stock has decreased by 39.0% and is now trading at $0.5860. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) issued its earnings results on Thursday, August, 15th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business earned $1.85 million during the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%. Who are Milestone Scientific's major shareholders? Top institutional investors of Milestone Scientific include Carnegie Investment Counsel (0.21%). Insiders that own company stock include SRL Bp4, Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard. View institutional ownership trends. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/15/2024Today8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:MLSS CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees30Year FoundedN/APrice Target and Rating Average Price Target for Milestone Scientific$1.25 High Price Target$1.25 Low Price Target$1.25 Potential Upside/Downside+104.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.93 million Net Margins-52.01% Pretax Margin-52.21% Return on Equity-60.26% Return on Assets-40.23% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio1.86 Sales & Book Value Annual Sales$8.61 million Price / Sales5.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book5.55Miscellaneous Outstanding Shares78,477,000Free Float58,614,000Market Cap$47.87 million OptionableOptionable Beta0.80 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:MLSS) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.